Daily Archives: April 2, 2020
CDC Guidance: Decontamination and Reuse of Filtering Facepiece Respirators
2 Apr, 2020 | 04:24h | UTC
Thu April 02 – 10 Stories of The Day!
2 Apr, 2020 | 04:29h | UTC
Related: An Ethicist on How to Make Impossible Decisions – The Atlantic
Commentaries: Coronavirus can spread one to three days before symptoms appear: CDC study – Reuters AND CDC Director warns 25 percent of COVID-19 cases may present no symptoms – New Atlas AND SARS-CoV-2 Readily Shed Early in Infection, Transmissible Before Symptoms Emerge – NEJM Journal Watch
Related: Yes, You Can Spread Coronavirus Even If You Don’t Have Symptoms – Self AND Infected but Feeling Fine: The Unwitting Coronavirus Spreaders – The New York Times AND COVID-19: Undocumented Infections are the Infection Source for 79% of Documented Cases
4 – Virological assessment of hospitalized patients with COVID-2019 – Nature
Commentaries: People with coronavirus may be most infectious in the first week of symptoms – MIT Technology Review AND Expert reaction to paper on ‘shedding’ of SARS-CoV-2 virus in 9 patients with COVID-19 – Science Media Centre
5 – Video: Coronavirus (COVID-19) Update: Critical Care Management – JAMA
See also: Other Reviews at Oxford COVID-19 Evidence Service
8 – Editorial: Ten Weeks to Crush the Curve – New England Journal of Medicine
9 – Audio Interview: Lessons from Covid-19 Hotspots – New England Journal of Medicine
10 – Coronavirus Disease (COVID-19) Updates / 02 April 2020 Edition
02 April 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)
Video: Coronavirus (COVID-19) Update: Critical Care Management
2 Apr, 2020 | 04:20h | UTCCoronavirus (COVID-19) Update: Critical Care Management – JAMA
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
2 Apr, 2020 | 04:21h | UTC
Another Study Shows Presymptomatic Transmission of SARS-CoV-2
2 Apr, 2020 | 04:26h | UTCCommentaries: Coronavirus can spread one to three days before symptoms appear: CDC study – Reuters AND CDC Director warns 25 percent of COVID-19 cases may present no symptoms – New Atlas AND SARS-CoV-2 Readily Shed Early in Infection, Transmissible Before Symptoms Emerge – NEJM Journal Watch
Related: Yes, You Can Spread Coronavirus Even If You Don’t Have Symptoms – Self AND Infected but Feeling Fine: The Unwitting Coronavirus Spreaders – The New York Times AND COVID-19: Undocumented Infections are the Infection Source for 79% of Documented Cases
Related Commentary on Twitter
New @CDCMMWR report on #COVID19 in Singapore shows that some clusters of cases likely resulted from people without symptoms spreading illness. Social distancing and avoiding crowds are key to slowing the spread of COVID-19. https://t.co/kRysZ9lxzO pic.twitter.com/4UJc0KCDPM
— CDC (@CDCgov) April 1, 2020
Evidence Review: In Patients of COVID-19, what Are the Symptoms and Clinical Features of Mild and Moderate Cases?
2 Apr, 2020 | 04:16h | UTCSee also: Other Reviews at Oxford COVID-19 Evidence Service
Virological Assessment of Hospitalized Patients with COVID-2019
2 Apr, 2020 | 04:14h | UTCVirological assessment of hospitalized patients with COVID-2019 – Nature
Commentaries: People with coronavirus may be most infectious in the first week of symptoms – MIT Technology Review AND Expert reaction to paper on ‘shedding’ of SARS-CoV-2 virus in 9 patients with COVID-19 – Science Media Centre
Editorial: Ten Weeks to Crush the Curve
2 Apr, 2020 | 04:17h | UTCTen Weeks to Crush the Curve – New England Journal of Medicine
Audio Interview: Lessons from Covid-19 Hotspots
2 Apr, 2020 | 04:08h | UTCAudio Interview: Lessons from Covid-19 Hotspots – New England Journal of Medicine
Universal Masking in Hospitals in the Covid-19 Era
2 Apr, 2020 | 04:05h | UTCUniversal Masking in Hospitals in the Covid-19 Era – New England Journal of Medicine
COVID-19: Ethical Guidance Published for Frontline Staff Dealing with Pandemic
2 Apr, 2020 | 04:11h | UTCEthical guidance published for frontline staff dealing with pandemic – Royal College of Physicians
Related: An Ethicist on How to Make Impossible Decisions – The Atlantic
Perspective: Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks
2 Apr, 2020 | 04:06h | UTC
ACC/AHA Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19) Pandemic
2 Apr, 2020 | 04:02h | UTC
[Abstract Only] Randomized Trial: Urgent vs. Early Endoscopy for Acute Upper GI Bleeding
2 Apr, 2020 | 03:58h | UTCTiming of Endoscopy for Acute Upper Gastrointestinal Bleeding – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: No Observed Benefit to Urgent Endoscopy for Upper GI Bleeding – NEJM Journal Watch
Use of Face Masks by the Population: The Debate Continues
2 Apr, 2020 | 04:04h | UTC- Everyone Thinks They’re Right About Masks – The Atlantic
- COMMENTARY: Masks-for-all for COVID-19 not based on sound data – CIDRAP
- You Still Probably Don’t Need A Mask For COVID-19 – Medium
- Everything you need to know about making your own face mask – Vox
- All Israelis must wear face-masks in public as virus precaution: Netanyahu – Reuters
- C.D.C. Weighs Advising Everyone to Wear a Mask – The New York Times
AGA Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic
2 Apr, 2020 | 04:01h | UTCNews Release: AGA issues formal recommendations for PPE during gastrointestinal procedures
New WHO Guide to Help Countries Expand Access to Essential Medicines
2 Apr, 2020 | 03:59h | UTCSelection of essential medicines at country level – World Health Organization
News Release: New WHO Guide to help countries expand access to essential medicines – World Health Organization
Study Evaluates Sensitivity and Specificity of New Multi-Cancer Detection Test
2 Apr, 2020 | 03:56h | UTC
Interactive Perspective: Tuberculosis in 2020 — New Approaches to a Continuing Global Health Crisis
2 Apr, 2020 | 03:57h | UTC
[Abstract Only] Randomized Trial: Efficacy of Levetiracetam, Fosphenytoin, and Valproate for Established Status Epilepticus by Age Group
2 Apr, 2020 | 03:54h | UTCEfficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial – The Lancet (link to abstract – $ for full-text)
Source: Grupo UTIclínica – HCFMUSP
Related Commentary on Twitter
NEW—Children, adults & older adults with established status epilepticus respond similarly to levetiracetam, fosphenytoin, & valproate, with treatment success in approximately half of patients: finding from ESETT, double-blind, responsive-adaptive, RCT https://t.co/zpjNdvMIGS pic.twitter.com/NecwRfGR23
— The Lancet (@TheLancet) March 25, 2020